Please login to the form below

Not currently logged in
Email:
Password:

tafenoquine

This page shows the latest tafenoquine news and features for those working in and with pharma, biotech and healthcare.

GSK cues up regulatory filings for relapsing malaria drug

GSK cues up regulatory filings for relapsing malaria drug

Armed with new phase III data, GlaxoSmithKline is planning regulatory filings for its one-dose antimalarial tafenoquine, which is designed to prevent relapses in patients infected with the parasite. ... A second trial called GATHER showed that there was

Latest news

  • Scientists finds new drug target for malaria Scientists finds new drug target for malaria

    Other drugs coming through development include GlaxoSmithKline's tafenoquine and Sanofi's OZ439 - both of which are aminoquinolines in phase II trials - and triazolopyrimidine candidate DSM265, which is being guided through

More from news
Approximately 1 fully matching, plus 1 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
bmore group

OUR PROMISE: BETTER HEALTH FROM TRIAL TO TREATMENT.We are a full service, independent network of specialist agencies under one roof....

Latest intelligence

InSite Mapping™ - a Novel Tool for Insight-gathering and Patient Journey Mapping
Learn how a client engaged 18 rheumatologist advisors over 6 months to create a patient journey map for SLE....
Alone we can do so little, together we can do so much
Collaboration is at the heart of successful patient engagement and effective healthcare provision. But in such a complex, nuanced network, true collaborations are rare. So how can we, as an...
7 important considerations for creating an inclusive clinical trial website
You might have noticed that all of us here at COUCH Health are big advocates for taking action to improve diversity and inclusion in the world of clinical research. ‘Taking...

Infographics